These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25354813)

  • 1. Oesophageal cancer: assessment of tumour response to chemoradiotherapy with tridimensional CT.
    Alfieri R; Pintacuda G; Cagol M; Occhipinti T; Capraro I; Scarpa M; Zanchettin G; Cavallin F; Michelotto M; Giacomelli L; Ancona E; Castoro C
    Radiol Med; 2015 May; 120(5):430-9. PubMed ID: 25354813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer.
    van Heijl M; Phoa SS; van Berge Henegouwen MI; Omloo JM; Mearadji BM; Sloof GW; Bossuyt PM; Hulshof MC; Richel DJ; Bergman JJ; Ten Kate FJ; Stoker J; van Lanschot JJ
    Eur J Surg Oncol; 2011 Dec; 37(12):1064-71. PubMed ID: 21944048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer.
    Konieczny A; Meyer P; Schnider A; Komminoth P; Schmid M; Lombriser N; Weishaupt D
    Eur Radiol; 2013 Sep; 23(9):2492-502. PubMed ID: 23645329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma.
    Blom RL; Steenbakkers IR; Lammering G; Vliegen RF; Belgers EJ; de Jonge C; Schreurs WM; Nap M; Sosef MN
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1500-6. PubMed ID: 23764889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
    Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy.
    Heethuis SE; van Rossum PS; Lips IM; Goense L; Voncken FE; Reerink O; van Hillegersberg R; Ruurda JP; Philippens ME; van Vulpen M; Meijer GJ; Lagendijk JJ; van Lier AL
    Radiother Oncol; 2016 Jul; 120(1):128-35. PubMed ID: 27296409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the computed tomography perfusion imaging improve the diagnostic accuracy in the response evaluation of esophageal carcinoma to the neoadjuvant chemoradiotherapy? Preliminary study.
    Djuric-Stefanovic A; Saranovic D; Micev M; Stankovic V; Plesinac-Karapandzic V; Pesko P; Stojakov D; Sabljak P; Bjelovic M
    J BUON; 2014; 19(1):237-44. PubMed ID: 24659670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
    Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
    JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
    Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
    Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of the metabolically active tumour volume].
    Paumier A; Marquis A; Trémolières P; Lacombe M; Capitain O; Septans AL; Peyraga G; Gustin P; Vénara A; Ménager É; Visvikis D; Couturier O; Rio E; Hatt M
    Cancer Radiother; 2016 Feb; 20(1):24-9. PubMed ID: 26762703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
    Calais J; Dubray B; Nkhali L; Thureau S; Lemarignier C; Modzelewski R; Gardin I; Di Fiore F; Michel P; Vera P
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):858-67. PubMed ID: 25680400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
    Piessen G; Petyt G; Duhamel A; Mirabel X; Huglo D; Mariette C
    Ann Surg; 2013 Jul; 258(1):66-76. PubMed ID: 23470576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between CT volume measurement and histopathological assessment of response to neoadjuvant therapy in rectal cancer.
    Pomerri F; Pucciarelli S; Gennaro G; Maretto I; Nitti D; Muzzio PC
    Eur J Radiol; 2012 Dec; 81(12):3918-24. PubMed ID: 22902408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
    Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
    Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer.
    Metser U; Rashidi F; Moshonov H; Wong R; Knox J; Guindi M; Darling G
    Ann Nucl Med; 2014 May; 28(4):295-303. PubMed ID: 24474598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degree of tumor shrinkage following neoadjuvant chemoradiotherapy: a potential predictor for complete pathological response in esophageal cancer?
    Voncken FE; Jiang H; Kim J; Guindi M; Brierley J; Knox J; Liu G; Horgan AM; Lister J; Darling G; Metser U; Wong RK
    Dis Esophagus; 2014 Aug; 27(6):552-9. PubMed ID: 23121504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
    Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
    Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach.
    Giorgetti A; Pallabazzer G; Ripoli A; Solito B; Genovesi D; Lencioni M; Fabrini MG; D'Imporzano S; Pieraccini L; Marzullo P; Santi S
    Medicine (Baltimore); 2016 Mar; 95(13):e3151. PubMed ID: 27043676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
    Elliott JA; O'Farrell NJ; King S; Halpenny D; Malik V; Muldoon C; Johnston C; Reynolds JV
    Br J Surg; 2014 Dec; 101(13):1702-11. PubMed ID: 25351460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.